Regulation of Rho GTPase Activity Through Phosphorylation Events: A Brief Overview

Chapter
First Online:

Abstract

As discussed in Parts I and II of this book the Rho GTPases are highly regulated in their ability to become activated. The concept that there are many more guanine exchange factorss and GTPase-activating proteinss than Rho proteins, and given the function of the Rho guanine dissociation inhibitors (RhoGDIs), they would lead to the conclusion that all regulation occurs on the level of the Rho regulatory proteins. However, evidence that implicates phosphorylation events as being additional mechanisms for controlling Rho activity and potential interactions with downstream effectors is emerging. This chapter provides a brief overview of Rho phosphorylation events via the activity of four well-studied protein kinases: protein kinase A, protein kinase B (aka Akt), protein kinase C, and protein kinase G.

Keywords

GTPase Activity Active RhoA Inflammatory Breast Cancer Cell RhoC GTPase SUM149 Inflammatory Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Aktories K, Braun U et al (1989) The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem Biophys Res Commun 158(1):209–213.CrossRefPubMedGoogle Scholar
  2. Chen Y, Wang Y et al (2005) The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells. Exp Biol Med (Maywood) 230(10):731–741.Google Scholar
  3. Dias SM, Cerione RA (2007) X-ray crystal structures reveal two activated states for RhoC. Biochemistry 46(22):6547–6558.CrossRefPubMedGoogle Scholar
  4. Dong G, Lee TL et al (2004) Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor. Oncogene 23(37):6199–6208.CrossRefPubMedGoogle Scholar
  5. Dong JM, Leung T et al (1998) cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J Biol Chem 273(35):22554–22562.CrossRefPubMedGoogle Scholar
  6. Ellerbroek SM, Wennerberg K et al (2003) Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278(21):19023–19031.CrossRefPubMedGoogle Scholar
  7. Faucheux N and Nagel MD (2002) Cyclic AMP-dependent aggregation of Swiss 3T3 cells on a cellulose substratum (Cuprophan) and decreased cell membrane Rho A. Biomaterials 23(11):2295–2301.CrossRefPubMedGoogle Scholar
  8. Forget MA, Desrosiers RR et al (2002) Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J 361(Pt 2):243–254.CrossRefPubMedGoogle Scholar
  9. Fukuda A, Hikita A et al (2005) Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J Bone Miner Res 20(12):2245–2253.CrossRefPubMedGoogle Scholar
  10. Geyer M, Wittinghofer A (1997) GEFs, GAPs, GDIs and effectors: taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins. Curr Opin Struct Biol 7(6):786–792.CrossRefPubMedGoogle Scholar
  11. Gosser YQ, Nomanbhoy TK et al (1997) C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 387(6635):814–819.CrossRefPubMedGoogle Scholar
  12. Hall A (1990) The cellular functions of small GTP-binding proteins. Science 249(4969):635–640.CrossRefPubMedGoogle Scholar
  13. Hori Y, Kikuchi A et al (1991) Post-translational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins. Oncogene 6(4):515–522.PubMedGoogle Scholar
  14. Hu CD, Kariya K et al (1999) Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. J Biol Chem 274(1):48–51.CrossRefPubMedGoogle Scholar
  15. Jelacic T, Linnekin D (2005) PKCdelta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant. Blood 105(5):1923–1929.CrossRefPubMedGoogle Scholar
  16. Kermorgant S, Zicha D et al (2004) PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J 23(19):3721–3734.CrossRefPubMedGoogle Scholar
  17. Kikkawa U, Takai Y et al (1983) Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J Biol Chem 258(19):11442–11445.PubMedGoogle Scholar
  18. Kwak JY, Uhlinger DJ (2000) Downregulation of phospholipase D by protein kinase A in a cell-free system of human neutrophils. Biochem Biophys Res Commun 267(1):305–310.CrossRefPubMedGoogle Scholar
  19. Kwon T, Kwon DY et al. (2000). Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J Biol Chem 275(1):423–428.CrossRefPubMedGoogle Scholar
  20. Lang P, Gesbert F et al (1996) Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 15(3):510–519.PubMedGoogle Scholar
  21. Lee HW, Smith L et al (1996) Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J Biol Chem 271(35):20973–20976.CrossRefPubMedGoogle Scholar
  22. Lerosey I, Pizon V et al (1991) The cAMP-dependent protein kinase phosphorylates the rap1 protein in vitro as well as in intact fibroblasts, but not the closely related rap2 protein. Biochem Biophys Res Commun 175(2):430–436.CrossRefPubMedGoogle Scholar
  23. Lu Z, Liu D et al (1998) Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 18(2):839–845.PubMedGoogle Scholar
  24. Nobes CD, Hall A (1995) Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 23(3):456–459.PubMedGoogle Scholar
  25. Nusser N, Gosmanova E et al (2006) Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF-induced neurite outgrowth. Cell Signal 18(5):704–714.CrossRefPubMedGoogle Scholar
  26. O’Connor KL, Nguyen BK et al (2000) RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J Cell Biol 148(2):253–258.CrossRefPubMedGoogle Scholar
  27. Olofsson B (1999) Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 11(8):545–554.CrossRefPubMedGoogle Scholar
  28. Overbeck AF, Brtva TR et al (1995) Guanine nucleotide exchange factors: activators of Ras superfamily proteins. Mol Reprod Dev 42(4):468–476.CrossRefPubMedGoogle Scholar
  29. Pan Q, Bao LW et al (2005) Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res 65(18):8366–8371.CrossRefPubMedGoogle Scholar
  30. Pan Q, Bao LW et al (2006) Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res 66(19):9379–9384.CrossRefPubMedGoogle Scholar
  31. Qiang YW, Yao L et al (2004) Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood 103(1):301–308.CrossRefPubMedGoogle Scholar
  32. Quilliam LA, Mueller H et al (1991) Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J Immunol 147(5):1628–1635.PubMedGoogle Scholar
  33. Ribeiro-Neto F, Urbani J et al (2002) On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b. Proc Natl Acad Sci U S A 99(8):5418–5423.CrossRefPubMedGoogle Scholar
  34. Ridley AJ, Paterson HF et al (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70(3):401–410.CrossRefPubMedGoogle Scholar
  35. Sanchez S, Jimenez C et al (2004) A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation. Neurochem Int 44(4):231–242.CrossRefPubMedGoogle Scholar
  36. Sauzeau V, Le Jeune H et al (2000) Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275(28):21722–21729.CrossRefPubMedGoogle Scholar
  37. Sawada N, Itoh H et al (2001) cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 280(3):798–805.CrossRefPubMedGoogle Scholar
  38. Sebok A, Nusser N et al (1999) Different roles for RhoA during neurite initiation, elongation, and regeneration in PC12 cells. J Neurochem 73(3):949–960.CrossRefPubMedGoogle Scholar
  39. Stahelin RV, Wang J et al (2005) The origin of C1A-C2 interdomain interactions in protein kinase Calpha. J Biol Chem 280(43):36452–36463.CrossRefPubMedGoogle Scholar
  40. Worden B, Yang XP et al (2005) Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Cancer Res 65(16):7071–7080.CrossRefPubMedGoogle Scholar
  41. Yanagawa T, Funasaka T et al (2004) Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat Cancer 11(4):749–759.CrossRefPubMedGoogle Scholar
  42. Yao H, Dashner EJ et al (2006) RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene 25(16):2285–2296.CrossRefPubMedGoogle Scholar
  43. Zhang QG, Wang XT et al (2006) Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury. J Neurochem 98(6):1886–1898.CrossRefPubMedGoogle Scholar
  44. Zhang X, Lin M et al (2005) Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration. Breast Cancer Res Treat 93(2):159–168.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Biological Sciences, Laboratory of Cytoskeletal PhysiologyUniversity of Delaware, Center for Translational Cancer ResearchNewarkUSA

Personalised recommendations